Bhavesh Shah, R.Ph, BCOP, earned a bachelor of science in pharmacy degree at Massachusetts College of Pharmacy and Health Sciences subsequent to receiving a biochemistry degree from Loyola University Chicago. A board-certified oncology pharmacist, Mr. Shah is presently the Chief Pharmacy Officer for Specialty and Hematology/Oncology Pharmacy Services at Boston Medical Center Health System a $8B enterprise. In this role, he is responsible for the clinical, research, payor and manufacturer contracting and operational efficiency of the cancer center, specialty pharmacy, cell, gene and precision medicine programs and various ambulatory specialty areas with revenue of $1.5B. Mr. Shah also oversees clinical and formulary support for specialty programs for BMC owned specialty pharmacy and regional managed care medicaid plan with over 800,000+ lives He has research experience is in COVID-19, biosimilzars, cancer-related anorexia and cachexia syndrome, prevention of chemotherapy-induced nausea and vomiting, treatment of iron deficiency anemia, lung cancer digital adherence technology, immune thrombocytopenia purpura, and inflammatory bowel disease. He is a reviewer for the Annals of Pharmacotherapy, American Journal of Health System Pharmacy and has written articles in the Journal of Oncology Pharmacy Practice, Supportive Care in Cancer, and Biology of Blood and Marrow Transplantation. Mr. Shah has presented both nationally and internationally on biosimilars, specialty pharmacy arena, 340b, and the field of hematology/oncology pharmacy.